CAR-T Drugs Break Ground For Stem Cell Therapies In CNS, Says Brainstorm CEO
Executive Summary
Brainstorm’s president and CEO Chaim Lebovits talks to Scrip about the company’s progress with personalized stem cell therapy NurOwn in ALS and what the future holds for cell therapy options in neurology.